ArriVent BioPharma, Inc. Share Price
NASDAQ: AVBP | Small CapArriVent BioPharma, Inc. Stock Performance
ArriVent BioPharma, Inc. Share Price Today
As of 29 October 2026, ArriVent BioPharma, Inc.'s share price is $16.36. The stock opened at $16.02, compared to its previous close of $15.72. During today's trading session, ArriVent BioPharma, Inc.'s share price traded between $16.00 and $16.29, with an average price of $16.14. Over the past 52 weeks, the stock has recorded a high of $35.59 and a low of $11.37. In terms of performance, ArriVent BioPharma, Inc.'s share price has declined by 47.40% over the last six months and is down 12.51% on a year-on-year basis.
ArriVent BioPharma, Inc. Share Price Chart
ArriVent BioPharma, Inc. Quarterly Profit & Loss
All figures in USD
ArriVent BioPharma, Inc. Annual Profit & Loss
All figures in USD
About ArriVent BioPharma, Inc.
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
ArriVent BioPharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $30.49 | $16.29 | -46.34% |
Sep 2026 | $30.19 | $30.36 | -2.46% |
Aug 2026 | $30.58 | $31.12 | +4.31% |
Jul 2026 | $34.92 | $29.84 | -14.09% |
Jun 2026 | $29.61 | $34.73 | +14.89% |
May 2026 | $30.96 | $30.23 | -2.80% |
Apr 2026 | $23.41 | $31.10 | +34.63% |
Mar 2026 | $22.79 | $23.10 | +0.20% |
Feb 2026 | $22.10 | $23.05 | +2.49% |
Jan 2026 | $20.47 | $22.50 | +11.75% |
Dec 2025 | $22.09 | $20.13 | -12.25% |
Nov 2025 | $18.14 | $22.94 | +22.67% |